Myasthenia gravis constitutes chronic autoimmune disease that primarily targets the neuromuscular junction. This junction facilitates the transmission of signals from nerves to muscles, enabling movement. In myasthenia gravis, the body's immune system incorrectly attacks these receptors, leading weakness and fatigue in the muscles. The indications